Pasha Aaron Jackson, MD
Family Practice · Richmond
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 8
Offices
8 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 057004 · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jackson’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$75,819
Medicare paid this office $75,819 for 136 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 99 | $26,568 | $108 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 29 | $15,938 | $149 |
| Long return visit (40+ min) | 36 | $8,458 | $157 |
| Short return visit (20+ min) | 49 | $4,590 | $71 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,062 | $290 |
See all 12 services
| Return visit (30+ min) | 99 | $26,568 | $108 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 29 | $15,938 | $149 |
| Long return visit (40+ min) | 36 | $8,458 | $157 |
| Short return visit (20+ min) | 49 | $4,590 | $71 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,062 | $290 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,583 | $156 |
| Influenza vaccine, inactivated | 42 | $3,436 | $82 |
| Sarscov2 vac 50 mcg/0.5ml im | 15 | $2,361 | $157 |
| Administration of influenza virus vaccine | 44 | $1,702 | $39 |
| Admn sarscov2 vacc 1 dose | 15 | $774 | $52 |
| Administration of pneumococcal vaccine | 14 | $542 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 12 | $222 | $15 |
Who their Medicare patients are
136 Original Medicare patients in 2024. Average age 73 · Under 65 13% · 85 and older 14% · Women 54% · Also on Medicaid 29% · Health risk score 1.49. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 70% · Diabetes 33% · Chronic kidney disease 28% · Depression 19% · Coronary heart disease 15% · Atrial fibrillation 15% · Heart failure 13% · Cancer 13%.
The office billed $248,575, Medicare allowed $99,806 and paid $75,819; for 687 services of 26 kinds; $9,948 of it was for drugs given in the office and $65,872 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 136 | 687 | 73 | 1.49 | $248,575 | $75,819 |
| 2023 | 110 | 528 | 73 | 1.45 | $195,391 | $60,767 |
| 2022 | 124 | 437 | 72 | 1.18 | $152,285 | $46,257 |
| 2021 | 107 | 460 | 71 | 1.12 | $141,013 | $44,095 |
| 2020 | 99 | 411 | 71 | 1.21 | $98,102 | $30,345 |
| 2019 | 61 | 150 | 73 | 0.96 | $32,937 | $10,932 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 33 | $17,146 | $150 |
| Return visit (30+ min) | 63 | $16,082 | $111 |
| Long return visit (40+ min) | 35 | $8,000 | $160 |
| Short return visit (20+ min) | 52 | $5,360 | $74 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $5,165 | $157 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 24 | $1,819 | $76 |
| Administration of influenza virus vaccine | 25 | $929 | $37 |
2022: 7 services
| Return visit (30+ min) | 68 | $14,920 | $104 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 27 | $9,288 | $143 |
| Long return visit (40+ min) | 39 | $6,866 | $132 |
| Short return visit (20+ min) | 42 | $4,713 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $4,674 | $156 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 23 | $1,616 | $70 |
| Administration of influenza virus vaccine | 24 | $878 | $37 |
2021: 7 services
| Return visit (30+ min) | 76 | $22,269 | $110 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 20 | $6,426 | $153 |
| Long return visit (40+ min) | 22 | $5,005 | $167 |
| Short return visit (20+ min) | 42 | $4,335 | $65 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,724 | $157 |
| Influenza vaccine split virus, preservative free | 11 | $718 | $65 |
| Administration of influenza virus vaccine | 11 | $230 | $21 |
2020: 7 services
| Return visit (30+ min) | 65 | $11,075 | $89 |
| Short return visit (20+ min) | 47 | $6,294 | $69 |
| New patient visit (45+ min) | 20 | $2,217 | $111 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $2,157 | $72 |
| New patient visit (30+ min) | 12 | $815 | $68 |
| Influenza vaccine split virus, preservative free | 13 | $779 | $60 |
| Administration of influenza virus vaccine | 17 | $349 | $21 |
2019: 4 services
| Return visit (30+ min) | 35 | $5,172 | $101 |
| Short return visit (20+ min) | 19 | $1,348 | $67 |
| Influenza vaccine split virus, preservative free | 16 | $862 | $54 |
| Administration of influenza virus vaccine | 16 | $323 | $20 |
Drugs they prescribed that Part D paid
$248,946
Pharmacies billed $248,946 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (143 of 2,755) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 11% of their opioid prescriptions.
2,504 generic and 236 brand-name prescriptions · $248,946 in drug cost · 63 antibiotic prescriptions to 25 people · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 22 | $36,032 | $1,638 |
| Eliquis | 19 | $31,949 | $1,682 |
| Ozempic | 17 | $20,841 | $1,226 |
| Januvia | 11 | $16,297 | $1,482 |
| Myrbetriq | 11 | $7,447 | $677 |
See all 64 drugs
| Jardiance | 22 | $36,032 | $1,638 |
| Eliquis | 19 | $31,949 | $1,682 |
| Ozempic | 17 | $20,841 | $1,226 |
| Januvia | 11 | $16,297 | $1,482 |
| Myrbetriq | 11 | $7,447 | $677 |
| Telmisartan | 86 | $3,551 | $41 |
| Oxycodone-Acetaminophen | 53 | $2,311 | $44 |
| Atorvastatin | 189 | $1,885 | $10 |
| Fluticasone Propionate | 13 | $1,833 | $141 |
| Diclofenac | 24 | $1,410 | $59 |
| Rosuvastatin | 62 | $1,217 | $20 |
| Metformin | 97 | $1,048 | $11 |
| Amlodipine Besylate | 166 | $982 | $6 |
| Mirtazapine | 24 | $976 | $41 |
| Lisinopril | 78 | $831 | $11 |
| Albuterol Sulfate Hfa | 26 | $794 | $31 |
| Phenobarbital | 12 | $726 | $60 |
| Ondansetron Odt | 14 | $725 | $52 |
| Carvedilol | 45 | $691 | $15 |
| Gabapentin | 47 | $665 | $14 |
| Tamsulosin | 36 | $649 | $18 |
| Hydrocodone-Acetaminophen | 42 | $627 | $15 |
| Potassium Chloride | 51 | $621 | $12 |
| Pantoprazole | 47 | $613 | $13 |
| Metoprolol | 44 | $604 | $14 |
| Mupirocin | 21 | $560 | $27 |
| Diltiazem 24hr Er (Cd) | 12 | $557 | $46 |
| Trazodone | 35 | $527 | $15 |
| Levothyroxine | 39 | $521 | $13 |
| Glipizide | 18 | $506 | $28 |
| Donepezil | 34 | $501 | $15 |
| Lamotrigine | 13 | $494 | $38 |
| Alendronate | 37 | $470 | $13 |
| Losartan | 47 | $437 | $9 |
| Tizanidine | 21 | $410 | $20 |
| Celecoxib | 11 | $396 | $36 |
| Cyclobenzaprine | 22 | $391 | $18 |
| Nortriptyline | 15 | $372 | $25 |
| Olmesartan Medoxomil | 11 | $351 | $32 |
| Metformin Hcl Er | 32 | $333 | $10 |
| Famotidine | 30 | $327 | $11 |
| Allopurinol | 26 | $323 | $12 |
| Pravastatin | 20 | $321 | $16 |
| Furosemide | 47 | $317 | $7 |
| Omeprazole | 35 | $291 | $8 |
| Hydrochlorothiazide | 37 | $242 | $7 |
| Sertraline | 12 | $239 | $20 |
| Acetaminophen-Codeine | 13 | $216 | $17 |
| Citalopram Hbr | 15 | $206 | $14 |
| Ramipril | 17 | $194 | $11 |
| Clopidogrel | 23 | $181 | $8 |
| Chlorthalidone | 13 | $164 | $13 |
| Atenolol | 20 | $157 | $8 |
| Triamterene-Hydrochlorothiazid | 13 | $137 | $11 |
| Tramadol | 17 | $135 | $8 |
| Montelukast | 11 | $117 | $11 |
| Metoprolol | 29 | $65 | $2 |
| Lorazepam | 21 | $58 | $3 |
| Diazepam | 17 | $43 | $3 |
| Clonazepam | 15 | $41 | $3 |
| Zolpidem | 12 | $40 | $3 |
| Simvastatin | 11 | $29 | $3 |
| Meloxicam | 13 | $19 | $1 |
| Alprazolam | 15 | $17 | $1 |
Year by year
| 2024 | 2,755 | 187 | 5% (143) | 9% | $248,946 |
| 2023 | 2,474 | 186 | 5% (128) | 10% | $271,365 |
| 2022 | 2,011 | 192 | 5% (108) | 12% | $185,802 |
| 2021 | 1,386 | 142 | 3% (41) | None | $85,859 |
| 2020 | 848 | 109 | 3% (26) | 11% | $45,012 |
| 2019 | 247 | 53 | None | None | $12,918 |
| 2018 | 39 | 12 | 0% (0) | 0% | $542 |
| 2017 | 50 | None | 0% (0) | None | $1,426 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 67 drugs
| Ozempic | 27 | $41,061 | $1,521 |
| Jardiance | 23 | $32,431 | $1,410 |
| Eliquis | 17 | $28,694 | $1,688 |
| Rybelsus | 14 | $14,560 | $1,040 |
| Invokana | 14 | $9,098 | $650 |
| Telmisartan | 53 | $3,541 | $67 |
| Atorvastatin | 181 | $2,825 | $16 |
| Lidocaine | 17 | $1,807 | $106 |
| Quetiapine | 24 | $1,756 | $73 |
| Rosuvastatin | 49 | $1,745 | $36 |
| Pantoprazole | 55 | $1,734 | $32 |
| Metformin | 102 | $1,728 | $17 |
| Diclofenac | 33 | $1,696 | $51 |
| Potassium Chloride | 43 | $1,563 | $36 |
| Amlodipine Besylate | 124 | $1,536 | $12 |
| Gabapentin | 44 | $1,404 | $32 |
| Hydrocodone-Acetaminophen | 66 | $1,369 | $21 |
| Lamotrigine | 11 | $1,320 | $120 |
| Celecoxib | 11 | $1,229 | $112 |
| Irbesartan | 16 | $1,142 | $71 |
| Nateglinide | 12 | $1,077 | $90 |
| Ipratropium | 17 | $1,037 | $61 |
| Tamsulosin | 37 | $894 | $24 |
| Losartan | 61 | $893 | $15 |
| Metoprolol | 20 | $770 | $39 |
| Lisinopril | 64 | $752 | $12 |
| Trazodone | 30 | $707 | $24 |
| Carvedilol | 38 | $697 | $18 |
| Levothyroxine | 33 | $677 | $21 |
| Olmesartan Medoxomil | 13 | $631 | $49 |
| Mirtazapine | 14 | $612 | $44 |
| Albuterol Sulfate Hfa | 17 | $565 | $33 |
| Alendronate | 29 | $560 | $19 |
| Allopurinol | 26 | $539 | $21 |
| Ciclopirox | 13 | $532 | $41 |
| Omeprazole | 34 | $517 | $15 |
| Glipizide | 24 | $510 | $21 |
| Cyclobenzaprine | 21 | $497 | $24 |
| Terazosin | 11 | $447 | $41 |
| Nortriptyline | 13 | $443 | $34 |
| Metformin Hcl Er | 25 | $442 | $18 |
| Phenobarbital | 13 | $416 | $32 |
| Furosemide | 47 | $415 | $9 |
| Oxycodone-Acetaminophen | 16 | $376 | $24 |
| Pregabalin | 11 | $376 | $34 |
| Pravastatin | 14 | $350 | $25 |
| Famotidine | 14 | $332 | $24 |
| Atenolol | 22 | $322 | $15 |
| Ramipril | 17 | $312 | $18 |
| Acetaminophen-Codeine | 17 | $267 | $16 |
| Donepezil | 23 | $257 | $11 |
| Hydrochlorothiazide | 34 | $253 | $7 |
| Amitriptyline | 14 | $244 | $17 |
| Clonazepam | 18 | $243 | $14 |
| Clopidogrel | 17 | $220 | $13 |
| Mupirocin | 14 | $201 | $14 |
| Lovastatin | 14 | $179 | $13 |
| Finasteride | 11 | $165 | $15 |
| Lorazepam | 16 | $159 | $10 |
| Simvastatin | 17 | $144 | $8 |
| Diazepam | 19 | $138 | $7 |
| Lisinopril-Hydrochlorothiazide | 12 | $133 | $11 |
| Metoprolol | 25 | $123 | $5 |
| Fluoxetine | 12 | $110 | $9 |
| Tramadol | 22 | $106 | $5 |
| Zolpidem | 15 | $86 | $6 |
| Alprazolam | 16 | $19 | $1 |
2022: 51 drugs
| Jardiance | 20 | $28,969 | $1,448 |
| Invokana | 16 | $15,846 | $990 |
| Eliquis | 16 | $11,513 | $720 |
| Atorvastatin | 141 | $1,683 | $12 |
| Telmisartan | 35 | $1,348 | $39 |
| Albuterol Sulfate Hfa | 29 | $1,208 | $42 |
| Lidocaine | 12 | $1,197 | $100 |
| Potassium Chloride | 36 | $1,175 | $33 |
| Losartan | 68 | $1,001 | $15 |
| Amlodipine Besylate | 112 | $998 | $9 |
| Irbesartan | 20 | $857 | $43 |
| Hydrocodone-Acetaminophen | 45 | $855 | $19 |
| Celecoxib | 13 | $790 | $61 |
| Pantoprazole | 53 | $762 | $14 |
| Diclofenac | 30 | $664 | $22 |
| Rosuvastatin | 31 | $567 | $18 |
| Metformin | 78 | $548 | $7 |
| Gabapentin | 36 | $535 | $15 |
| Metoprolol | 22 | $530 | $24 |
| Tamsulosin | 21 | $518 | $25 |
| Levothyroxine | 22 | $487 | $22 |
| Lisinopril | 47 | $446 | $9 |
| Carvedilol | 32 | $398 | $12 |
| Pregabalin | 16 | $393 | $25 |
| Acetaminophen-Codeine | 24 | $385 | $16 |
| Cyclobenzaprine | 25 | $378 | $15 |
| Nystatin | 14 | $325 | $23 |
| Furosemide | 34 | $299 | $9 |
| Clopidogrel | 16 | $290 | $18 |
| Omeprazole | 34 | $289 | $9 |
| Duloxetine | 11 | $282 | $26 |
| Propranolol | 13 | $246 | $19 |
| Hydrochlorothiazide | 32 | $237 | $7 |
| Trazodone | 25 | $224 | $9 |
| Glipizide | 22 | $182 | $8 |
| Lisinopril-Hydrochlorothiazide | 17 | $177 | $10 |
| Allopurinol | 12 | $177 | $15 |
| Lovastatin | 17 | $168 | $10 |
| Atenolol | 24 | $166 | $7 |
| Diazepam | 31 | $162 | $5 |
| Famotidine | 16 | $157 | $10 |
| Meloxicam | 12 | $134 | $11 |
| Naproxen | 14 | $116 | $8 |
| Hydrocortisone | 13 | $110 | $8 |
| Losartan-Hydrochlorothiazide | 11 | $95 | $9 |
| Ibuprofen | 11 | $82 | $7 |
| Oxycodone-Acetaminophen | 11 | $71 | $6 |
| Tramadol | 13 | $63 | $5 |
| Metoprolol | 11 | $41 | $4 |
| Simvastatin | 13 | $36 | $3 |
| Alprazolam | 11 | $13 | $1 |
2021: 38 drugs
| Eliquis | 13 | $6,909 | $531 |
| Mirtazapine | 15 | $991 | $66 |
| Irbesartan | 26 | $912 | $35 |
| Potassium Chloride | 31 | $907 | $29 |
| Diclofenac | 26 | $891 | $34 |
| Atorvastatin | 87 | $844 | $10 |
| Albuterol Sulfate Hfa | 19 | $838 | $44 |
| Telmisartan | 17 | $757 | $45 |
| Amlodipine Besylate | 75 | $736 | $10 |
| Pantoprazole | 36 | $560 | $16 |
| Losartan | 32 | $474 | $15 |
| Omeprazole | 36 | $464 | $13 |
| Levothyroxine | 20 | $457 | $23 |
| Gabapentin | 43 | $349 | $8 |
| Rosuvastatin | 20 | $341 | $17 |
| Famotidine | 13 | $332 | $26 |
| Hydrocodone-Acetaminophen | 17 | $309 | $18 |
| Lisinopril | 36 | $309 | $9 |
| Triamcinolone Acetonide | 21 | $279 | $13 |
| Metformin | 37 | $255 | $7 |
| Trazodone | 19 | $248 | $13 |
| Metoprolol | 21 | $239 | $11 |
| Carvedilol | 20 | $220 | $11 |
| Clopidogrel | 24 | $213 | $9 |
| Fluoxetine | 16 | $175 | $11 |
| Diazepam | 25 | $157 | $6 |
| Hydrocortisone | 11 | $150 | $14 |
| Finasteride | 14 | $137 | $10 |
| Hydrochlorothiazide | 24 | $134 | $6 |
| Lisinopril-Hydrochlorothiazide | 15 | $130 | $9 |
| Pregabalin | 12 | $125 | $10 |
| Atenolol | 20 | $118 | $6 |
| Amitriptyline | 14 | $98 | $7 |
| Ibuprofen | 11 | $78 | $7 |
| Lovastatin | 12 | $70 | $6 |
| Sertraline | 11 | $63 | $6 |
| Simvastatin | 11 | $61 | $6 |
| Cyclobenzaprine | 12 | $55 | $5 |
2020: 26 drugs
| Brilinta | 14 | $2,841 | $203 |
| Diclofenac | 26 | $1,464 | $56 |
| Atorvastatin | 38 | $537 | $14 |
| Gabapentin | 35 | $495 | $14 |
| Albuterol Sulfate Hfa | 11 | $434 | $39 |
| Potassium Chloride | 18 | $433 | $24 |
| Amlodipine Besylate | 44 | $428 | $10 |
| Omeprazole | 24 | $322 | $13 |
| Atenolol | 26 | $270 | $10 |
| Amitriptyline | 13 | $214 | $16 |
| Metformin | 28 | $210 | $8 |
| Duloxetine | 11 | $186 | $17 |
| Lisinopril | 18 | $185 | $10 |
| Trazodone | 11 | $180 | $16 |
| Losartan | 15 | $164 | $11 |
| Fluoxetine | 15 | $156 | $10 |
| Levetiracetam | 11 | $146 | $13 |
| Clopidogrel | 17 | $140 | $8 |
| Hydrochlorothiazide | 20 | $126 | $6 |
| Tamsulosin | 13 | $118 | $9 |
| Hydrocodone-Acetaminophen | 14 | $117 | $8 |
| Sertraline | 11 | $101 | $9 |
| Ibuprofen | 12 | $98 | $8 |
| Furosemide | 15 | $96 | $6 |
| Nortriptyline | 12 | $93 | $8 |
| Diazepam | 11 | $67 | $6 |
2019: 7 drugs
| Baclofen | 11 | $284 | $26 |
| Atorvastatin | 18 | $238 | $13 |
| Levothyroxine | 12 | $185 | $15 |
| Amlodipine Besylate | 11 | $164 | $15 |
| Topiramate | 20 | $133 | $7 |
| Levetiracetam | 19 | $121 | $6 |
| Tamsulosin | 11 | $73 | $7 |
Professional record
- NPI
- 1487000790
- Licence
- CA 1170636
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-05-05
- NPI last updated
- 2023-12-13
- NPI record certified
- 2023-12-13
This is when the NPI record was last certified, not a medical board exam.